08/20/2026
One painting. One very special artist. One purpose.
If you have ever wondered about the “elyn” in Andelyn, meet Evelyn.
Evelyn is one of two pioneering gene therapy patients whose names came together to form Andelyn. Born with spinal muscular atrophy (SMA), Evelyn received an investigational gene therapy at just eight weeks old as part of a Phase I clinical trial in 2015. Four years later, the therapy was approved by the FDA.
Her story, along with Andrew’s, became part of the Andelyn name and continues to remind us of the patients and families at the heart of why this work matters.
Now, we are incredibly grateful to have something created by Evelyn herself as part of our 2026 Fore One Purpose Silent Auction. This one-of-a-kind watercolor brings together so much of what this event represents: patients, possibility and hope carried forward.
Our Silent Auction is LIVE, with this year’s event benefiting Drake, Vivian and their family.
Bid on Evelyn’s painting: https://fore-one-purpose-silent-auction-2026.perfectsilentauction.com/